Phoenix
  • About
  • Team
  • Strategic Partners
  • Advisors
  • Companies
  • Testimonials
  • News
  • Incubators
  • LP Portal
  • Contact
Select Page
ReForm Biologics and KBI Biopharma Announce Strategic Partnership to Improve Biopharmaceutical Formulations and Development.

ReForm Biologics and KBI Biopharma Announce Strategic Partnership to Improve Biopharmaceutical Formulations and Development.

Apr 16, 2018 | News, Press Release

Collaboration will provide clients competitive advantages, improve speed to market. KBI makes equity investment in ReForm Biologics along with existing investors. CAMBRIDGE, Mass. and Durham, NC – April 4, 2018 – ReForm Biologics and KBI Biopharma, Inc., (KBI) today...

Recent Posts

  • Pesticide alternative coats crops to hide them from insects
  • AbSci Announces Acquisition of Deep Learning Company Denovium
  • NBD Nanotechnologies announces InvisiPrint® MBED™, an anti-fingerprint coating with embedded antimicrobial protection
  • AbSci Announces $65 Million Financing Led by Casdin Capital
  • Months after striking a deal with Sanofi, AbSci nails its largest fundraise yet to support its protein printing tech

Archives

  • ►2021
    • January
  • ►2020
    • December
    • October
    • September
    • August
    • June
    • May
    • March
    • February
  • ►2019
    • November
    • August
    • May
    • April
    • March
    • January
  • ►2018
    • October
    • September
    • August
    • July
    • May
    • April
    • March
    • February
  • ►2017
    • December
    • November
    • October
    • July
    • June
    • May
    • March
    • February
    • January
  • ►2016
    • October
    • September
    • August
    • May
    • April
  • ►2015
    • October
    • August
  • ►2013
    • September
  • ►2012
    • October
    • April
    • March
    • February
    • January

Categories

  • Article
  • Interview
  • News
  • Press Release
  • Show All
Please note that use of this website is subject to your acceptance of the TERMS AND CONDITIONS OF USE AND PRIVACY POLICY. I am not a resident of the European Union.OkNoPrivacy Policy